Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)

NCT05973604 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT05973604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05973604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
September 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, primary aldosteronism